Latest news with #JackHartung
Yahoo
14-06-2025
- Automotive
- Yahoo
Tesla (NasdaqGS:TSLA) Sees 30% Price Jump Over Last Quarter
Tesla has recently undergone notable changes, including the resignation of Milan Kovac from the Optimus humanoid robot program and the addition of Jack Hartung to its board. These executive adjustments join amendments in company bylaws as Tesla adapts to legislative changes in Texas. Despite these events, Tesla's 30% price increase over the last quarter could be seen in the context of broader market growth of 11% over the past year. The company's adjustments may have added weight to Tesla's upward trend, but other factors would also play a role in this growth. Every company has risks, and we've spotted 2 weaknesses for Tesla you should know about. We've found 20 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. The recent executive changes at Tesla, including Milan Kovac's departure and Jack Hartung's board appointment, come as the company undergoes legislative adaptations in Texas. These shifts may exert influence on Tesla's ambitious projects such as autonomous vehicles and humanoid robots, potentially affecting revenue streams and profit margins due to changes in operational focus or strategy. Considering Tesla's 387.53% total return over five years, its long-term performance remains robust, markedly outpacing recent broader market growth, which returned 11% over the past year. This historical context highlights Tesla's ability to achieve significant returns despite short-term fluctuations. Notably, Tesla's price increase over the last quarter aligns with executive changes, perhaps reflecting market confidence in adapted leadership and strategic direction. However, the current share price of US$275.35 positions it near the analyst consensus price target of US$289.44, indicating limited expected room for upside in the near term. The company's future revenue growth, pegged at 16.6% annually over the next three years, and expected earnings increase to US$14.7 billion, hinge on successful execution of its ventures into autonomous technology and energy sectors. These projections, although optimistic, underline the importance of Tesla mitigating execution risks to align realized performance with market expectations. Click here and access our complete financial health analysis report to understand the dynamics of Tesla. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NasdaqGS:TSLA. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Yahoo
22-05-2025
- Business
- Yahoo
Coinbase on S&P 500, Novavax vaccine, Tesla: Trending Tickers
Coinbase Global (COIN) will begin trading on the S&P 500 (^GSPC) effective today, replacing Discover Financial Services (DFS) on the exchange. The US Food and Drug Administration (FDA) approves Novavax's (NVAX) COVID-19 vaccine, sending the pharmaceutical stock surging. Tesla (TSLA) is adding former Chipotle Mexican Grill (CMG) CFO Jack Hartung to its board of directors, effective June 1, when Hartung will be stepping down as the restaurant chain's president and chief strategy officer. To watch more expert insights and analysis on the latest market action, check out more Catalysts here. It's now time for some of today's trending takers. This morning we're watching Coinbase, Novavax and Tesla. First up, Coinbase officially replacing Discover Financial Services on the S&P 500. Coinbase is the first crypto firm to join the index. Here's what CEO Brian Armstrong told Yahoo Finance's Jennifer Schonberger about the inclusion. Coinbase joining the S&P 500 means crypto's here to stay. It's going to be in everybody's 401Ks. Um everyone's going to have crypto exposure, you know, at least indirectly through Coinbase, which is great. Stock was up more than 30% last week ahead of the inclusion despite news of a hack that is expected to cost the company over $400 million. Still here with me to discuss we have Amy Woo Silverman. Amy, I know you look at the options market when you're talking about individual stocks. What are you seeing around Coinbase? It's really interesting because I think just what Armstrong had sent there is very symbolic of kind of old guard being transferred to new guard. Um in terms of Coinbase specifically around the options, it's just this idea overall that if crypto becomes normalized, you're going to really see a change in correlations. And what I mean by that is cryptocurrency in general has really been this risk on asset and Coinbase to some degree has traded along with that correlation, but as it becomes thought of more as just a normal part of what people as he said have in their 401Ks, I think it then people start rethinking its relationship. Maybe it acts like digital gold. Maybe it really is an inflation hedge. We're not seeing those yet, but I do think you start to see investors think of both Coinbase and crypto in general as part of that cohort and managing those risks. Yeah, something of a change to what drives the trade on that stock potentially. Really interesting. We're going to move on though to Novavax's COVID vaccine getting full approval from the FDA. This after the clearance was delayed when Health and Human Services Secretary, Robert F. Kennedy Jr. raised doubts about its efficacy. The shot is cleared for adults 65 and older and those ages 12 to 64 who have at least one underlying condition that puts them at high risk. Of course, this comes amid record COVID cases in parts of the globe. We got the shares up 10%, but Amy, they were up as much as 18% earlier today. I'm interested in why the street sees this as such a big catalyst for Novavax. Yeah, I think it's just comes down to what was priced in prior and then the surprise that they got so it perhaps that had something to do with it. I will tell you in general when you think about not only the options for Novavax, but U&H for healthcare, it's been incredibly elevated when we look at our liquid universe of all sectors. Healthcare has across the board had held the most uncertainty related to what Trump has hang, but also related, I would say to just much more idiosyncratic risk related to a lot of these factors like FDA approval or maybe the disapproval of a trial that you don't get in other stocks. Perhaps a signal of how much policy uncertainty there is in that sector. So much. Yeah, absolutely. Really good stuff. We're also going to talk about Tesla leading declines among the magnificent seven today. The electric vehicle maker adding a new board member, retired CFO, Jack Hartung's appointment is effective coming up on June 1st, but Tesla again leading declines in the mag 7 this morning is down a little over 2%. This is always a fun one to talk options on Amy. What are you seeing with Tesla? So I will tell you Tesla is a name I never want to give up on because when I think back to its options history, it has the most severe form of what we call skew inversion, but it's a really simple way of saying, I've never seen such exuberance in the call options as I have on a stock like Tesla, and that's faded a lot, but we always watch for if that ticks back because that creates enormous amount of momentum in the stock that you have to be careful of. It happens in Tesla, maybe Nvidia, but not very many names exhibit this the way you see in Tesla. How can investors monitor that? So take a look at how the call option pricing trades relative to the put option pricing when that starts to go kind of above and beyond what the normal relationship of that spread is, then you're starting to see that momentum build in the stock again. Really, really important context there, Amy. Thank you so much. For our audience, you can scan the QR code below to track the best and worst performing stocks with the Yahoo finances at trending at ticker's page. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
19-05-2025
- Automotive
- Yahoo
Tesla stock is down to start the week. A new Model Y rival in China could be why.
Tesla (TSLA) stock is down to start the week, with news out of China perhaps weighing on the stock. Xiaomi (XIACY) said on its Weibo account that it will officially unveil is YU7 this week, a midsize crossover EV that will go head to head with Tesla's Model Y. The Chinese device and upstart EV-maker said the YU7 will be revealed at Xiaomi's strategic new product launch event happening on Thursday May 22; a render of the EV was shown late last year. Chinese EV blog CnEVPost was the first to spot the post. Xiaomi's SU7 EV sedan has been a huge hit with its domestic audience, with the Porsche ( Taycan/McLaren supercar-looking design selling 135,000 units in 2024, with expectations for sales to more than double in 2025. Xiaomi did not reveal any sales expectations for the YU7, or when it was expected in showrooms. The SU7, with its striking looks and tech-forward interior powered by a version of Android called HyperOS, has clearly been a hit with Chinese consumers who look to their cars as extensions of their digital devices. Expectations are for the YU7 to follow a similar path to success. Tesla stock slipped in early trade, down 3%. News of a rival competitor in one of Tesla's biggest markets certainly isn't helping the stock, though the tech sector in the US is also trading lower on economic and debt concerns. Tesla bulls are not complaining about recent performance, however. Tesla capped off another strong week last Friday, marking four straight weeks of gains and cutting its year to date losses to around 16%. Tesla's addition of Chipotle president Jack Hartung to its board of directors helped boost the stock last week. Hartung could aid the board in its quest to explore 'alternative ways' to compensate CEO Elon Musk after a Delaware judge invalidated his $56 billion pay package. Musk's big bet on Tesla's future and its trillion dollar market cap lies with the company's autonomous ambitions, with the company set to test unsupervised robotaxis in Austin this summer. Morgan Stanley analyst Adam Jonas and select clients met with Tesla's head of investor relations to talk about the state of autonomous last week. Key headlines from the meeting were Tesla's Austin's fleet size would be very low, 'think 10 to 20 cars' Jonas wrote, with 'plenty of tele-ops' to ensure safety, meaning human intervention from remote locations when a robotaxi needed assistance. With companies like Alphabet's Waymo already performing 250,000 robotaxi rides per week in the US, Tesla is behind the ballwith ramping up its robotaxi offering. Tesla and Musk argue that its vision-based system is more scalable, and that the company already has millions of EVs out on the road already capable of doing self-driving once software development is complete, and its AI-based systems trained. That's a big if. The National Highway Traffic Safety Administration (NHTSA) is currently investigating the safety of Tesla's FSD (full-self driving) system, and submitted a detailed questionnaire for answers regarding Tesla's 'development of technologies for use in 'robotaxi' vehicles to understand how Tesla plans to evaluate its vehicles and driving automation technologies for use on public roads.' Regulators closing examining Tesla's robotaxi testing gamelan may push the company's robotaxi timing out more that the company would like. Pras Subramanian is a reporter for Yahoo Finance. You can follow him on X and on Instagram.
Yahoo
19-05-2025
- Automotive
- Yahoo
Tesla stock is down to start the week. A new Model Y rival in China could be why
Tesla (TSLA) stock is down to start the week, with news out of China perhaps weighing on the stock. Xiaomi (XIACY) said on its Weibo account that it will officially unveil is YU7 this week, a midsize crossover EV that will go head to head with Tesla's Model Y. The Chinese device and upstart EV-maker said the YU7 will be revealed at Xiaomi's strategic new product launch event happening on Thursday May 22; a render of the EV was shown late last year. Chinese EV blog CnEVPost was the first to spot the post. Xiaomi's SU7 EV sedan has been a huge hit with its domestic audience, with the Porsche ( Taycan/McLaren supercar-looking design selling 135,000 units in 2024, with expectations for sales to more than double in 2025. Xiaomi did not reveal any sales expectations for the YU7, or when it was expected in showrooms. The SU7, with its striking looks and tech-forward interior powered by a version of Android called HyperOS, has clearly been a hit with Chinese consumers who look to their cars as extensions of their digital devices. Expectations are for the YU7 to follow a similar path to success. Tesla stock slipped in early trade, down 3%. News of a rival competitor in one of Tesla's biggest markets certainly isn't helping the stock, though the tech sector in the US is also trading lower on economic and debt concerns. Tesla bulls are not complaining about recent performance, however. Tesla capped off another strong week last Friday, marking four straight weeks of gains and cutting its year to date losses to around 16%. Tesla's addition of Chipotle president Jack Hartung to its board of directors helped boost the stock last week. Hartung could aid the board in its quest to explore 'alternative ways' to compensate CEO Elon Musk after a Delaware judge invalidated his $56 billion pay package. Musk's big bet on Tesla's future and its trillion dollar market cap lies with the company's autonomous ambitions, with the company set to test unsupervised robotaxis in Austin this summer. Morgan Stanley analyst Adam Jonas and select clients met with Tesla's head of investor relations to talk about the state of autonomous last week. Key headlines from the meeting were Tesla's Austin's fleet size would be very low, 'think 10 to 20 cars' Jonas wrote, with 'plenty of tele-ops' to ensure safety, meaning human intervention from remote locations when a robotaxi needed assistance. With companies like Alphabet's Waymo already performing 250,000 robotaxi rides per week in the US, Tesla is behind the ballwith ramping up its robotaxi offering. Tesla and Musk argue that its vision-based system is more scalable, and that the company already has millions of EVs out on the road already capable of doing self-driving once software development is complete, and its AI-based systems trained. That's a big if. The National Highway Traffic Safety Administration (NHTSA) is currently investigating the safety of Tesla's FSD (full-self driving) system, and submitted a detailed questionnaire for answers regarding Tesla's 'development of technologies for use in 'robotaxi' vehicles to understand how Tesla plans to evaluate its vehicles and driving automation technologies for use on public roads.' Regulators closing examining Tesla's robotaxi testing gamelan may push the company's robotaxi timing out more that the company would like. Pras Subramanian is a reporter for Yahoo Finance. You can follow him on X and on Instagram. Sign in to access your portfolio
Yahoo
19-05-2025
- Business
- Yahoo
Coinbase on S&P 500, Novavax vaccine, Tesla: Trending Tickers
Coinbase Global (COIN) will begin trading on the S&P 500 (^GSPC) effective today, replacing Discover Financial Services (DFS) on the exchange. The US Food and Drug Administration (FDA) approves Novavax's (NVAX) COVID-19 vaccine, sending the pharmaceutical stock surging. Tesla (TSLA) is adding former Chipotle Mexican Grill (CMG) CFO Jack Hartung to its board of directors, effective June 1, when Hartung will be stepping down as the restaurant chain's president and chief strategy officer. To watch more expert insights and analysis on the latest market action, check out more Catalysts here.
